VCEL Short Volume
Vericel Corporation (VCEL) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.68B, listed on NASDAQ, employing roughly 357 people, carrying a beta of 1.16 to the broader market. Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. Led by Dominick C. Colangelo, public since 1997-02-04.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-05-15
- Short Volume
- 77.8K
- Total Volume
- 126.7K
- Short %
- 61.42%
- 30-Day Avg Short %
- 47.42%
Showing 30 days of FINRA short volume data for Vericel Corporation.
Learn how short volume is reported and how to read the data →
Frequently asked VCEL short volume questions
- What is the daily VCEL short volume?
- As of May 15, 2026, Vericel Corporation (VCEL) short volume is 77.8K shares against 126.7K total reported volume, or 61.42% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is VCEL short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does VCEL short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.